Applied Pharmaceutical Nanotechnology 2019

October 25, 2019


1 Portland Street

Cambridge, MA 02139 


APN 2019 Conference Program


Plenary Speakers for APN 2019


Greg Troiano, MSE, Vice President of Technology and Chief Engineer, Seer, Inc.

Biomolecular Biosensors for Health Monitoring and Disease Detection - An Update


Ulrich von Andrian, M.D., Ph.D. Mallinckrodt Professor of Immunopathology, Harvard Medical School

Using Nanomaterials to Communicate with the Immune System


Confirmed Speakers for APN 2019


Zohreh Amoozgar, PhD, Post Doctoral Research Fellow, Harvard Medical School at Massachusetts General Hospital

Reprogramming the Tumor Microenvironment to Improve Immunotherapy


Gilles Besin, PhD, Sr. Director, Immunology, Moderna Therapeutics

Accelerated Blood Clearance of Lipid Nanoparticles Entails a Biphasic Humoral Response of B-1 Followed by B-2 Lymphocyte to Distinct Antigenic Moieties


Zhaohua Richard Huang, PhD, Senior Director of Research and Development, L.E.A.F. Pharmaceuticals

Case Studies on CMC and Regulatory Challenges of Liposomal Drug Development


Hakho Lee, Ph.D., Associate Professor, Harvard Medical School 

Promise of Liquid Biopsy for Cancer Management


Christopher Locher, Ph.D., CEO and Founder, Versatope Therapeutics 

Membrane Vesicles for Vaccine and Therapeutic Delivery


Shiladitya Sengupta, Ph.D., Associate Professor of Medicine, Harvard Medical School and Assistant Professor of Health Sciences and Technology, MIT

Understanding Cancer Immune Interactions at the Nanoscale: Going beyond T cell immune checkpoints


Young-Ho Song, Pfizer 

 A Novel in situ Hydrophobic Ion Paring (HIP) Formulation Strategy for Clinical Product Selection of a Nanoparticle Drug Delivery System


Gokul Swaminathan, PhD, Associate Principal Scientist, Merck Exploratory Science Center, Merck Research Laboratories

Novel Immuno-Modulatory Lipid Nanoparticle Formulations for Vaccines and Immuno-Oncology Applications


Shraddha Thakkar, PhD, Principal Investigator, U.S. FDA

Title TBA


Proposed Sessions for 2019: 

Session I: Particle Technology : Early and Late Stage Technology

Session II: Impact of Biology and Immunology in Nanotechnology

Session III: Regulatory Aspects of Nanotechnology




Please Join our Linkedin Group


Session I: Particle Technology : Early and Late Stage Technology

Session II: Impact of Biology and Immunology in Nanotechnology

Session III: Regulatory Aspects of Nanotechnology


Click here to register for the APN 2019 conference online.

APN 2019 will take place October 25, 2019 at:

Pfizer, Cambridge, MA


The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3


Sign Up Today!

Privacy Policy